Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2024-10-14 Governance Information
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
选聘会计师事务所管理制度
Governance Information Classification · 95% confidence The document is titled '选聘会计师事务所管理制度' which translates to 'Management System for the Selection of Accounting Firms'. It details the company's internal policies and procedures for selecting, appointing, and managing accounting firms for audit purposes. It includes sections on the legal basis, quality requirements, selection methods, procedures, supervision, and responsibilities related to the appointment of auditors. There is no actual financial data, audit report, or financial statements included. The document is a governance-related policy document rather than an audit report or annual report. It is not a brief announcement or a certification letter but a detailed internal governance document. Therefore, the most appropriate classification is Governance Information (CGR). The document length (5798 characters) supports it being a full policy document rather than a short announcement.
2024-10-14 Chinese
第八届监事会第十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 13th meeting of the 8th Supervisory Board of Ningbo New Zhi Biotechnology Co., Ltd. It details meeting attendance, agenda items, voting results, and references to related announcements on the Beijing Stock Exchange information disclosure platform. The content focuses on board-level decisions regarding acquisition of minority interests, auditor reappointment, and adjustment of funds usage limits. It is not a full financial report, audit report, or earnings release, but rather a corporate governance announcement about board resolutions. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is an announcement of meeting resolutions, not a full report or transcript.
2024-10-14 Chinese
关于收购控股子公司少数股东股权暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the acquisition of minority shareholders' equity in a controlled subsidiary and related party transactions. It includes detailed information about the transaction, the parties involved, financial data of the subsidiary, board and supervisory committee approvals, and risk disclosures. The document does not contain full financial statements or comprehensive financial performance data but focuses on a specific capital transaction and related disclosures. This fits the definition of a Capital/Financing Update (CAP) as it updates on company fundraising and capital structure changes. The document length is 4548 characters, which is sufficient for a detailed announcement rather than a brief notice. Therefore, the appropriate classification is CAP with high confidence.
2024-10-14 Chinese
高级管理人员任命公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a senior management personnel, specifically the company's new financial officer. It details the appointment decision, qualifications, and the approval process by the board and audit committee. There is no financial data, report, or presentation included. The document fits the category of Board/Management Information (MANG) as it announces changes in senior management.
2024-10-14 Chinese
关于召开 2024 年第三次临时股东大会通知公告（提供网络投票）
Regulatory Filings Classification · 95% confidence The document is a notice announcing the convening of the company's 2024 third extraordinary general meeting of shareholders. It includes details about the meeting date, voting methods, agenda items to be discussed, and registration procedures. It does not contain any financial statements, audit results, or detailed financial data. The document is relatively short (2831 characters) and serves as an announcement for the meeting rather than a report or results of the meeting. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-10-14 Chinese
中信证券股份有限公司关于宁波新芝生物科技股份有限公司收购控股子公司少数股东股权暨关联交易的专项核查意见
M&A Activity Classification · 85% confidence The document is a detailed regulatory disclosure by the sponsor and listed company regarding the planned acquisition of minority shareholdings in its subsidiary, including transaction background, pricing, approvals, and related-party considerations. It is not an earnings release, audit, or management change notice, but an announcement of an equity acquisition transaction. This aligns with M&A Activity (Code: TAR).
2024-10-14 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.